After successfully piloting a regimen of ivermectin, diethylcarbamazine citrate and albendazole (IDA) against lymphatic filariasis (LF) last year, Karnataka’s Yadgir district in India will undertake a second round of the triple-drug LF therapy from December 15-24. Meanwhile, the country also launched mass drug administration events on December 21 in eight districts of Uttar Pradesh and in Assam’s Dibrugarh district to combat the disease. National Vector Borne Disease Control Programme; India Ministry of Health
Menu